SIGLEC1 and breast carcinoma: Using co-cultures of macrophages and autologous NK cells together with MDA-MB-231 breast cancer cells revealed that presence of CD169+ Mo-M significantly reduced NK cell tumoricidal capacity, in contrast to presence of M1-macrophages (Figure 5C).